Status:
UNKNOWN
Maekmoondong-tang on Post-operative Cough in Patients With Lung Cancer
Lead Sponsor:
Seong-Gyu Ko
Conditions:
Postoperative Cough
Lung Cancer
Eligibility:
All Genders
20+ years
Phase:
PHASE2
PHASE3
Brief Summary
The aim of the present study is to evaluate the efficacy and safety of Maekmoondong-tang on post-operative cough in patients with lung cancer. A randomized, double-blind, placebo-controlled trial will...
Eligibility Criteria
Inclusion
- Adults over 20 years old.
- Patients undergone segmentectomy or lobectomy for lung cancer within 1 month
- Patients who do not or poorly respond to one week administration of common antitussive agents.
- Eastern Cooperative Oncology Group(ECOG) 0 to 2
- Participant is willing and able to give informed consent for participation in the study
Exclusion
- Patients undergoing adjuvant chemotherapy.
- Patients who have been diagnosed with acute respiratory disease within 1 month.
- Patients who have been diagnosed with bronchial asthma or bronchiectasis within 1 year
- Patients taking Angiotensin Converting Enzyme Inhibitor
- Patients with pseudoaldosteronism.
- Participants who have known prior hypersensitivity to any investigational product component
- Patient with acute or chronic infections requiring treatment (active HAV, HBV, HCV, HIV, TB)
- Pregnant or lactating females
- Women of childbearing potential
- Patient who do not agrees to use effective means of contraception and not to donate sperm during the trial and up to 1 month after final administration
- Patient who participated other clinical trials of medicine or medical devices within 1 month
- Individuals who are judged inappropriate for the study by investigator
Key Trial Info
Start Date :
February 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2019
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT03384667
Start Date
February 22 2018
End Date
March 31 2019
Last Update
February 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Guro Hospital
Seoul, South Korea, 130-701